Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$16.95 - $27.04 $1.78 Million - $2.84 Million
-104,847 Reduced 44.86%
128,851 $3.48 Million
Q1 2024

May 15, 2024

BUY
$11.38 - $19.03 $1.02 Million - $1.7 Million
89,344 Added 61.89%
233,698 $4.28 Million
Q4 2023

Feb 14, 2024

SELL
$6.29 - $15.72 $2.64 Million - $6.6 Million
-419,720 Reduced 74.41%
144,354 $1.77 Million
Q2 2023

Aug 14, 2023

SELL
$29.76 - $46.14 $9.18 Million - $14.2 Million
-308,383 Reduced 35.35%
564,074 $18.3 Million
Q1 2023

May 15, 2023

BUY
$38.09 - $57.79 $11.9 Million - $18.1 Million
312,583 Added 55.83%
872,457 $34.1 Million
Q4 2022

Feb 14, 2023

BUY
$40.54 - $56.2 $22.1 Million - $30.7 Million
546,016 Added 3940.08%
559,874 $29.6 Million
Q3 2022

Nov 14, 2022

BUY
$36.98 - $49.2 $512,468 - $681,813
13,858 New
13,858 $624,000
Q3 2021

Nov 15, 2021

SELL
$44.0 - $65.8 $2.37 Million - $3.55 Million
-53,951 Reduced 73.77%
19,183 $1.06 Million
Q2 2021

Aug 16, 2021

SELL
$44.66 - $63.06 $3.11 Million - $4.4 Million
-69,742 Reduced 48.81%
73,134 $3.5 Million
Q1 2021

May 17, 2021

BUY
$46.31 - $62.7 $5.22 Million - $7.06 Million
112,637 Added 372.49%
142,876 $7.24 Million
Q4 2020

Feb 16, 2021

BUY
$55.51 - $69.94 $1.68 Million - $2.11 Million
30,239 New
30,239 $1.9 Million
Q3 2019

Nov 14, 2019

SELL
$31.65 - $46.94 $9.16 Million - $13.6 Million
-289,489 Closed
0 $0
Q2 2019

Aug 15, 2019

BUY
$32.5 - $49.12 $2.41 Million - $3.65 Million
74,251 Added 34.5%
289,489 $14 Million
Q2 2019

Aug 14, 2019

BUY
$32.5 - $49.12 $7 Million - $10.6 Million
215,238 New
215,238 $921,000

Others Institutions Holding SILK

About Silk Road Medical Inc


  • Ticker SILK
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 37,565,600
  • Market Cap $1.03B
  • Description
  • Silk Road Medical, Inc. operates as a medical device company in the United States. The company offers various products for the treatment of carotid artery disease called transcarotid artery revascularization. Its products include ENROUTE Transcarotid Neuroprotection System that is used to directly access the common carotid artery and initiate te...
More about SILK
Track Israel Englander's Portfolio

Track Israel Englander Portfolio

Follow Israel Englander (Millennium Management LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.